Hyperuricemia as a Predictor of in-hospital Mortality in Acute Exacerbation of COPD: Insights from a Tertiary Care Hospital in Karachi
Keywords:
hyperuricemia, COPD exacerbation, COPD, in-hospital mortality, prognostic biomarker, , tertiary care hospital KarachiAbstract
OBJECTIVE: To identify the correlation of hyperuricemia with in-hospital mortality in patients who report to a tertiary care hospital in Karachi with acute exacerbation of chronic obstructive pulmonary disease (AECOPD).
METHODOLOGY: This cross-sectional study was conducted from May to October 2024 at Jinnah Postgraduate Medical Centre (Ward 12, Chest Medicine Centre), Karachi, Pakistan. A total of 150 patients with AECOPD were included via non-probability consecutive sampling. Inclusion criteria comprised: age 40 years, confirmed COPD diagnosis via spirometry with reversibility (post-bronchodilator FEV1/FVC <0.70), and hospitalization for AECOPD (Anthonisen's criteria). Exclusion criteria included chronic kidney disease, gout, coexisting pulmonary diseases, uncontrolled comorbidities affecting uric acid levels, and pregnancy. Data on demographics, serum uric acid levels, and outcomes were collected. Statistical analysis was performed using SPSS version 26, employing Chi-square tests and one-way ANOVA to assess associations between hyperuricemia, age, COPD duration, and mortality.
RESULTS: The cohort consisted of 71% males and 29% females, with 79% reporting a history of smoking. Hyperuricemia (>7 mg/dL) was significantly associated with in-hospital mortality (p = 0.001). A linear correlation was observed between age and uric acid levels (p = 0.014), but no association was found with COPD duration (p = 0.902). The mortality rate was 70%, higher than global averages, likely due to delayed presentations and limited ICU resources.
CONCLUSION: Hyperuricemia was identified as a predictor of in-hospital mortality among patients with AECOPD. Early intervention and monitoring of elevated uric acid levels can improve clinical outcomes in this high-risk patient population.
References
1. Mei F, Dalmartello M, Bonifazi M, Bertuccio P, Levi F, Boffetta P et al. Chronic obstructive pulmonary disease (COPD) mortality trends worldwide: An update to 2019. Respirology. 2022; 27(11): 941-50.
2. Aletaha R, Shamekh A, Tahmasbi F, Sullman MJ, Arshi S, Kolahi A-A. Burden of Chronic Obstructive Pulmonary Disease for 70-Year-old Adults and Older in Iran During 1990-2021. Int J Aging. 2024; 2(1): e10-e.
3. Saeed S, Siddiqui M, Altaf R. The Obstructive Lung Diseases Program: Integrated obstructive lung disease services within primary care in Pakistan. Pak J Med Sci. 2022; 38(2): 334.
4. Wattanachayakul P, Rujirachun P, Charoenngam N, Ungprasert P. Chronic obstructive pulmonary disease (COPD) is associated with a higher level of serum uric acid. A systematic review and meta-analysis. Adv Respir Med. 2020; 88(3): 215-22.
5. Büyükbayram G, Yüceer Ö, Oymak FS. The Relationship between Serum Uric Acid Levels and Early Mortality in Chronic Obstructive Pulmonary Disease Cases during Exacerbation. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases. 2022; 39(2).
6. Bartlett LG. Defining the pathophysiological impact of cigarette smoke extract in mice as a model for Chronic Obstructive Pulmonary Disease (COPD): University of Nottingham; 2024.
7. Adeloye D, Chua S, Lee C, Basquill C, Papana A, Theodoratou E et al. Global and regional estimates of COPD prevalence: Systematic review and meta-analysis. J Glob Health. 2015; 5(2): 020415.
8. Chan-Yeung M, Aït-Khaled N, White N, Ip MS, Tan WC. The burden and impact of COPD in Asia and Africa. Int J Tuberc Lung Dis. 2004; 8(1): 2-14.
9. Viegi G, Maio S, Fasola S, Baldacci S. Global burden of chronic respiratory diseases. J Aerosol Med Pulmonary Drug Delivery. 2020; 33(4): 171-7.
10. Park JH, Jo Y-I, Lee J-H. Renal effects of uric acid: hyperuricemia and hypouricemia. Korean J Intern Med. 2020; 35(6): 1291.
11. Borghi C, Agabiti-Rosei E, Johnson RJ, Kielstein JT, Lurbe E, Mancia G et al. Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease. Eur J Internal Med. 2020; 80: 1-11.
12. Pelaia C, Pastori D, Armentaro G, Miceli S, Cassano V, Barbara K et al. Predictors of renal function worsening in patients with chronic obstructive pulmonary disease (COPD): a multicenter observational study. Nutrients. 2021; 13(8): 2811.
13. Qian Y, Cai C, Sun M, Lv D, Zhao Y. Analyses of factors associated with acute exacerbations of chronic obstructive pulmonary disease: a review. Int J Chronic Obstruct Pulmon Dis. 2023: 2707-23.
14. Lange P, Ahmed E, Lahmar ZM, Martinez FJ, Bourdin A. Natural history and mechanisms of COPD. Respirology. 2021; 26(4): 298-321.
15. Choi JY, Rhee CK. Diagnosis and treatment of early chronic obstructive lung disease (COPD). J Clin Med. 2020; 9(11): 3426.
16. Wang X, Cheng Z. Cross-sectional studies: strengths, weaknesses, and recommendations. Chest. 2020; 158(1): S65-S71.
17. Zafar S, Qamar N, Shahid M, Kamran S, Sundus S, Aziz Z. Stanniocalcin 2 Expression: A Significant Marker in the Prognosis of Colorectal Carcinoma: Prognosis of Colorectal Carcinoma. Pak J Health Sci. 2024: 169-73.
18. Bhardwaj R, Agrawal U, Vashist P, Manna S. Determination of sample size for various study designs in medical research: A practical primer. J Fam Med Prim Care. 2024; 13(7): 2555-61.
19. Moriña A. When people matter: The ethics of qualitative research in the health and social sciences. Health Soc Care Commun. 2021; 29(5): 1559-65.
20. Association WM. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human participants. JAMA. 2024.
21. Abal? H, Önür ST, Aky?l FT, Demir D, Sökücü SN, Boyrac? N. Are Uric Acid and Uric Acid Creatinine Ratio Predictors for Mortality in Acute Exacerbations of Chronic Obstructive Pulmonary Disease? Bat? Karadeniz T?p Dergisi. 2022; 6(2): 142-9.
22. Sunnetcioglu A, Çilingir BM, Çelikel M, Bedirhanoglu S, Demirkiran H. Predictive risk factors for Intensive Care Unit mortality in Acute Exacerbations of COPD requiring Invasive Mechanical Ventilation. Eastern J Med. 2022; 27(4): 579-84.
23. Ogan N, Günay E, Baha A, Çandar T, Akp?nar EE. The effect of serum electrolyte disturbances and uric acid level on the mortality of patients with acute exacerbation of chronic obstructive pulmonary disease. Turkish Thoracic J. 2020; 21(5): 322.
24. Zhao L, Li Y, Yao D, Sun R, Liu S, Chen X, et al. Pharmacological basis for use of a novel compound in hyperuricemia: anti-hyperuricemic and anti-inflammatory effects. Front Pharmacology. 2021; 12: 772504.
25. Patanwar S, Chakraborti A, Kumar L, Vohra V, Tayal D. Serum Uric Acid and Clinical Outcome of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Med J Dr DY Patil University. 2020; 13(6): 658-64.
26. Yang H, Wang Z, Xiao S, Dai C, Wen X, Wu F et al. Association between serum uric acid and lung function in people with and without chronic obstructive pulmonary disease. Int J Chronic Obstruct Pulmon Dis. 2022: 1069-80.
27. Wang Y, Zhang W, Qian T, Sun H, Xu Q, Hou X et al. Reduced renal function may explain the higher prevalence of hyperuricemia in older people. Sci Reports. 2021; 11(1): 1302.
28. Winder M, Owczarek AJ, Mossakowska M, Broczek K, Grodzicki T, Wierucki ?, Chudek J. Prevalence of hyperuricemia and the use of allopurinol in older poles - results from a population-based PolSenior Study. Int J Environ Res Public Health. 2021; 18(2): 387.
29. Borghi C, Agnoletti D, Cicero AFG, Lurbe E, Virdis A. Uric acid and hypertension: a review of evidence and future perspectives for the management of cardiovascular risk. Hypertension. 2022; 79(9): 1927-36.
30. Priyanto A, Abdillah A, Fauziyah L. The Correlation between Physical Activity and Stress and their impact on Uric Acid Levels in older Individuals. Int J Nurs Midwif Sci. 2023; 7(3): 387-93.
31. Rotaru L, Groppa L, Codreanu CO, Spinei L, Arnaut O, Russu E, et al. Characteristics of clinical manifestations of gout in the elderly people. Roman J Rheumatology. 2022; 3: 118-23.
32. Babu M, Shiva N, Karthick N, Dinesh S, Nadu T, Dinesh S et al. Correlation of Serum Uric Acid Levels with Disease Severity in COPD Patients: A Cross-Sectional Study at a Tertiary Care Hospital.
33. Albano GD, Gagliardo RP, Montalbano AM, Profita M. Overview of the mechanisms of oxidative stress: impact in inflammation of the airway diseases. Antioxidants. 2022; 11(11): 2237.
34. Lin C-R, Tsai P-A, Wang C, Chen J-Y, editors. The Association between Uric Acid and Metabolic Syndrome in a Middle-Aged and Elderly Taiwanese Population: A Community-Based Cross-Sectional Study. Healthcare; 2024: MDPI.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Journal of Liaquat University of Medical & Health Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Submission of a manuscript to the journal implies that all authors have read and agreed to the content of the undertaking form or the Terms and Conditions.
When an article is accepted for publication, the author(s) retain the copyright and are required to grant the publisher the right of first publication and other non-exclusive publishing rights to JLUMHS.
Articles published in the Journal of Liaquat University of Medical & health sciences are open access articles under a Creative Commons Attribution-Noncommercial - Share Alike 4.0 License. This license permits use, distribution and reproduction in any medium; provided the original work is properly cited and initial publication in this journal. This is in accordance with the BOAI definition of open access. In addition to that users are allowed to remix, tweak and build upon the work non-commercially as long as appropriate credit is given and the new creations are licensed under the identical terms. Or, in certain cases it can be stated that all articles and content there in are published under creative commons license unless stated otherwise.
